Atlas Trials

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

Clinical trial NCT03278483 · COMPLETED

Trial details

NCT number
NCT03278483
Sponsor
Instituto Nacional de Salud Publica, Mexico
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes MellitusTuberculin (Skin Test) Positive
Start date
2019-02-28
Primary completion
2019-02-28
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.